NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹25 Cr | ₹-69 Cr | ₹-136 Cr | ₹38 Cr | ₹-114 Cr |
What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹-69 Cr |
| Mar2023 | ₹-136 Cr |
| Mar2022 | ₹38 Cr |
| Mar2021 | ₹-114 Cr |
How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | Positive | |
| Mar2024 | ₹-69 Cr | Negative | |
| Mar2023 | ₹-136 Cr | Negative | |
| Mar2022 | ₹38 Cr | Positive | |
| Mar2021 | ₹-114 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹15,915.8 Cr | 4.8% | -4.6% | 0.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 4.8% |
-4.6% |
0.7% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses